[Treatment of juvenile myoclonic epilepsy with low-dose sodium valproate]
1Clinique Neurologique, CHU Bretonneau, Tours.
Abstract:
Eleven patients with Juvenile Myoclonic Epilepsy were treated using small doses of a sustained-release form of valproic acid (500 mg/day). This treatment has lasted for an average of 33 months (8-69) and has been continued in all of the patients. None of them has experienced a new generalized tonic-clonic seizure. The myoclonias have become considerably less frequent and less intense. No side-effects have been spontaneously reported by the group of patients. Thus, we suggest to start newly diagnosed patients on small doses of valproic acid.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...


